Riskpilot← Back to searchSign inGet full accessPlastikkirurgi i Blekinge AB
ABActiveOrg 5567911655Högliden 2Medical specialists activities · NACE 8622Est. 20091-4 employees
Revenue 2024
SEK 3,9M
0% vs 2023
EBITDA margin
33.5%
+24% vs 2023
Equity ratio
62.3%
Financial strength
Net profit 2024
SEK 839K
+26% vs 2023
| Revenue | SEK 3,9M | +0% |
| EBITDA | SEK 1,3M | +24% |
| Net profit | SEK 839K | +26% |
| Total assets | SEK 4,7M | +20% |
| Equity | SEK 2,9M | +27% |
| Employees | — | — |
Legal name
Plastikkirurgi i Blekinge AB
Org number
5567911655
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 oktober 2009
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva läkarpraktik med plastikkirurgi som specialitet, förvaltning av fastigheter och värdepapper samt därmed förenlig verksamhet.
Address
Högliden 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 878 | 2 708 | 4 274 | 3 864 | 3 883 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 026 | 673 | 1 299 | 1 052 | 1 300 |
| Depreciation & amort. | −149 | −109 | −30 | −34 | −34 |
| EBIT | 877 | 564 | 1 269 | 1 018 | 1 266 |
| Net financials | — | — | — | −2 | 17 |
| Profit before tax | 730 | 469 | 955 | 848 | 1 068 |
| Tax | −164 | −101 | −204 | −183 | −229 |
| Net profit | 566 | 368 | 751 | 665 | 839 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 351 | 2 832 | 3 925 | 3 932 | 4 729 |
| Equity | 1 477 | 1 645 | 2 196 | 2 311 | 2 945 |
| Long-term debt | 6 | 8 | 62 | 14 | 31 |
| Short-term debt | 157 | 374 | 549 | 320 | 251 |
| Total debt | 163 | 382 | 611 | 334 | 282 |
EBITDA margin
33.5%
This company
15.8%
Market median
+112% vs market
20202024
Equity ratio
62.3%
This company
38.2%
Market median
+63% vs market
20202024
Return on equity
28.5%
This company
18.4%
Market median
+55% vs market
20202024
Net profit margin
21.6%
This company
8.1%
Market median
+167% vs market
20202024
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
20202024
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NE Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
BH | Audit | 2020 – 2022 |
CU Chief Auditor | Chief Auditor | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Plastikkirurgi i Blekinge AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt-Ola Håkan Månsson | Audit | 0 companies |
| Nils Erik Hagstedt | Chief Auditor | 0 companies |
| Cecilia Ulla Maria Wahlman | Chief Auditor | 0 companies |
| Jenny Sofia Hoffner | Deputy Board Member | 0 companies |
| Paul Mattias Hoffner | Board of Directors | 0 companies |